Find Grants for Municipalities, Political Subdivisions, and State Governments

Find out if you qualify for verified grants for Municipalities, Political Subdivisions, and State Governments . Discover your eligibility and key funding details for Municipalities, Political Subdivisions, and State Governments from major foundations and government agencies.

Total Dollars Available
$ 100 Trillion

Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-112

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.865, 93.173

Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-113

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.865, 93.173

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-243

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.393

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Deadline: November 16, 2027


Opportunity Number: PAR-25-244

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 16, 2027

Status: Posted

CFDA Numbers: 93.393

Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-25-038

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2026


Opportunity Number: PAR-25-037

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-228

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.879, 93.172

Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

Deadline: September 7, 2027


Opportunity Number: PAR-25-229

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2027

Status: Posted

CFDA Numbers: 93.172, 93.879

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

Deadline: January 7, 2027


Opportunity Number: PAR-25-069

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2027


Opportunity Number: PAR-25-070

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.393

NCMRR Early Career Research Award (R03 Clinical Trial Optional)

Deadline: January 7, 2028


Opportunity Number: PAR-25-124

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

NICHD Small Research Grant Program (R03 Clinical Trial Required)

Deadline: January 7, 2028


Opportunity Number: PA-25-125

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.865

NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

Deadline: November 12, 2027


Opportunity Number: PAR-25-204

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 12, 2027

Status: Posted

CFDA Numbers: 93.279

NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

Deadline: January 7, 2028


Opportunity Number: PAR-25-105

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.121

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-065

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242, 93.866

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-064

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.866, 93.242

Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-039

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-040

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Deadline: November 6, 2026


Opportunity Number: PAR-25-095

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 6, 2026

Status: Posted

CFDA Numbers: 93.172, 93.393, 93.866, 93.121

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Deadline: November 17, 2026


Opportunity Number: PAR-25-096

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 17, 2026

Status: Posted

CFDA Numbers: 93.393, 93.121, 93.172, 93.866

Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-067

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)

Deadline: September 7, 2026


Opportunity Number: PAR-25-066

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

Deadline: July 7, 2026


Opportunity Number: PAR-25-110

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: July 7, 2026

Status: Posted

CFDA Numbers: 93.279, 93.855, 93.865, 93.242, 93.313

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

Deadline: July 6, 2026


Opportunity Number: PAR-25-111

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: July 6, 2026

Status: Posted

CFDA Numbers: 93.855, 93.279, 93.313, 93.865

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Deadline: February 8, 2027


Opportunity Number: RFA-MH-26-170

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: February 8, 2027

Status: Posted

CFDA Numbers: 93.273, 93.213, 93.866, 93.867, 93.242, 93.286, 93.853, 93.865, 93.173, 93.279

×

Request Grant Support from GTC 360° Advisors

Our expert team at GTC 360° Advisors can help develop your grant strategy, recruit partner organizations, write your full proposal, compile and manage your budgets, and help you submit a compelling and compliant proposal on time.